Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3

EU orphan designation number: EU/3/04/235
Active ingredient: Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3
Indication: Treatment of Type B extreme insulin resistance syndrome
Sponsor: Insmed Europe Ltd
Compass House, Vision Park, Chivers Way, Histon, Cambridge CB 4 9AD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/10/2004 Orphan Designation EMEA/OD/071/04 (2004)4196 of 20/10/2004
18/07/2006 Corrigendum (2006)4196 corr of 14/07/2006
02/01/2007 Transfer of orphan designation EMEA/OD/071/04/T/01 (2006)6846 of 14/12/2006
08/05/2007 Removal of orphan designation from Community Register